1. 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants. (9th November 2020) Authors: Booty, Matthew; Stockmann, Adam; Pryor, Olivia; Myint, Melissa; Trumpfheller, Christine; Nicolini, Valeria; Klein, Christian; Codarri, Laura; Umana, Pablo; Sharei, Armon; Bernstein, Howard; Seidl, Katherine; Loughhead, Scott Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗